Journal
FEBS LETTERS
Volume 592, Issue 22, Pages 3759-3768Publisher
WILEY
DOI: 10.1002/1873-3468.13271
Keywords
protein engineering; selenoproteins; seryl-tRNA synthetase; synthetic biology; tRNA
Funding
- National Institute of General Medical Sciences [R35GM122560]
- Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG02-98ER20311]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122560] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Selenocysteine (Sec) lacks a cognate aminoacyl-tRNA synthetase. Instead, seryl-tRNA synthetase (SerRS) produces Ser-tRNA(Sec), which is subsequently converted by selenocysteine synthase to Sec-tRNA(Sec). Escherichia coli SerRS serylates tRNA(Sec) poorly; this may hinder efficient production of designer selenoproteins in vivo. Guided by structural modelling and selection for chloramphenicol acetyltransferase activity, we evolved three SerRS variants capable of improved Ser-tRNA(Sec) synthesis. They display 10-, 8-, and 4-fold increased k(cat)/K-M values compared to wild-type SerRS using synthetic tRNA(Sec) species as substrates. The enzyme variants also facilitate in vivo read-through of a UAG codon in the position of the critical serine(146) of chloramphenicol acetyltransferase. These results indicate that the naturally evolved SerRS is capable of further evolution for increased recognition of a specific tRNA isoacceptor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available